Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Diagnostics Lines Up Big Investment Plans In India; Makes Progress In Personalized Medicines

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Roche Diagnostics has planned significant investments in India to expand the reach of its products

You may also be interested in...



Roche CNS Partnering Global Head Sarah Holland On Collaborations In CNS: An Interview With PharmAsia News (Part 1 of 2)

Roche Global Head, CNS Partnering Sarah Holland talked to PharmAsia News' Australia bureau along the sidelines at Ausbiotech in Melbourne, Australia, recently about Roche's new R&D approach to partnering via therapeutic areas. Before joining Roche in 2005, Holland was Global Brand Director at AstraZeneca.

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

SC070987

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel